News

 

Overview

Media Contact

Dana Griffin
Communications Manager
646.257.3006
publicrelations@youngsurvival.org

Organization Profile

YSC is the premier global organization dedicated to the critical issues unique to young women with breast cancer. YSC offers resources, connections and outreach so young women feel supported, empowered and hopeful. With an interactive website, active online community and nearly 30 affiliates nationwide, YSC aims to ensure that no young woman faces breast cancer alone.

Corporate Support

YSC’s community of support welcomes members from the corporate world. Our Partners and Sponsors help make programs, resources and outreach availble to young women who really need them.  Studies show that customers appreciate this generosity, too: 79% will opt for companies who support good causes.1

YSC Statements/Press Releases

1 Cone/Duke University Behavioral Cause Study, 2008.

RSS: Breast Cancer Headlines

Breast Cancer Headlines


Triple-Negative BRCA Has Higher Mortality Risk
Women with so-called triple-negative breast cancer had nearly three times the risk of death from the disease as women with the most common form of the disease, researchers reported.

Thu, 03 May 2012 15:55:32 -0400

Sorafenib Combo Ups PFS but Toxicity Is High
Sorafenib plus chemotherapy improved progression-free survival in women with advanced breast cancer, but toxicity levels were deemed 'unacceptable,' according to new trial results.

Wed, 02 May 2012 11:46:38 -0400

Cryoablation OK in Breast Ca Metastasis
SAN FRANCISCO -- Cryoablation of metastatic breast cancer tumors in the liver, kidney, lung, and soft tissues appears safe and may be a cost-effective means of managing the disease, researchers said here.

Wed, 28 Mar 2012 14:49:51 -0400

SABCS: Liposomal Doxorubicin Safe in Advanced Breast Ca
SAN ANTONIO -- Women with advanced breast cancer who have been pretreated with anthracyclines can be safely treated with nonpegylated liposomal doxorubicin (Myocet) along with docetaxel (Taxotere) with little effect on cardiac risk, researchers reported here.

Mon, 12 Dec 2011 21:56:19 -0400

SABCS: Silent Brain Mets Common in Breast Cancer
SAN ANTONIO -- Asymptomatic brain metastases observed in magnetic resonance imaging studies appear to be common in women diagnosed with stage 4 breast cancer, researchers said here.

Sat, 10 Dec 2011 10:00:00 -0400

SABCS: Surgery May Help in Advanced Breast Cancer
SAN ANTONIO -- Surgical removal of primary breast cancer tumors in women who present with metastatic disease might improve local disease control and possibly overall survival, researchers suggested here.

Fri, 09 Dec 2011 13:15:56 -0400

SABCS: Bevacizumab Slows Metastatic Breast Cancer
SAN ANTONIO -- Women with metastatic HER2-positive breast cancer appeared to gain a disease-free survival benefit when bevacizumab was added to first-line therapy with trastuzumab and docetaxel, results of a large, randomized trial showed.

Thu, 08 Dec 2011 17:45:36 -0400

SABCS: Novel Agent Helps Slow Advanced Breast Ca
SAN ANTONIO -- Adding the investigative agent pertuzumab to the attack against the family of HER2 genes appears to markedly slow progression of metastatic breast cancer, researchers found.

Thu, 08 Dec 2011 12:34:58 -0400

SABCS: Addition of Everolimus Helps Slow Breast Cancer
SAN ANTONIO -- The combination of everolimus (Afinitor) and the aromatase inhibitor exemestane (Aromasin) extended progression-free survival in women diagnosed with metastatic breast cancer by more than four months, researchers said here.

Wed, 07 Dec 2011 18:30:00 -0400

Vaccine May Slow Advance of Breast, Ovarian Cancers
Ovarian and breast cancer patients with limited tumor burden and minimal prior chemotherapy may benefit from a recombinant poxviral vaccine, according to researchers with the National Cancer Institute.

Tue, 08 Nov 2011 20:06:15 -0400

ASTRO: Neoadjuvant Endocrine Tx Viable in ER Positive Cancer
MIAMI BEACH -- Neoadjuvant endocrine therapy is a potential alternative to pre-surgery cytotoxic chemotherapy in patients with locally advanced estrogen receptor-positive breast cancer, a single-center study suggested.

Sat, 08 Oct 2011 12:38:10 -0400

ASTRO: Breast Cancer Type Predicts Brain Mets Outcome
MIAMI BEACH -- Survival among women with breast cancer who developed brain metastases was influenced by cancer subtype, a researcher said here.

Wed, 05 Oct 2011 13:19:41 -0400

ECCO-ESMO: Drug Combo Works in Triple-Negative Breast Cancer
STOCKHOLM -- In clinical practice, bevacizumab (Avastin) plus paclitaxel (Taxol) works about as well for patients with triple-negative metastatic breast cancer as it does for those without triple-negative disease, researchers said here.

Fri, 30 Sep 2011 15:55:19 -0400

ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx
STOCKHOLM -- Adding the PARP inhibitor iniparib to gemcitabine (Gemzar) plus carboplatin (Paraplatin) may benefit triple-negative metastatic breast cancer patients when used as second- or third-line therapy, researchers said here.

Thu, 29 Sep 2011 17:42:27 -0400

ECCO-ESMO: HER2 Drug No Help With Breast Cancer Complications
STOCKHOLM -- Complication rates -- and costs -- tied to chemotherapy in metastatic breast cancer are not mitigated by the addition of anti-HER2 therapy, researchers said here.

Thu, 29 Sep 2011 13:00:00 -0400

View all
Newly Diagnosed
Resource Kit
Learn more and order

Info Just for you

Get Involved
Find an event or Ride TdP

What's new

Sign up to receive e-newsletters from YSC.

Please leave this field empty

FIND LOCATIONS

GO
Website Design by Blue Fountain Media

ENGLISH CONTENT